Litcius/Paper detail

Mechanisms Underlying the Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis

Thomas Kirwin, A.S.L. Gomes, Ravi Amin, Annam Sufi, Sahil Goswami, Brian Wang

2021Regenerative Medicine29 citationsDOIOpen Access PDF

Abstract

Atherosclerosis is a chronic inflammatory condition resulting in the formation of fibrofatty plaques within the intimal layer of arterial walls. The identification of resident stem cells in the vascular wall has led to significant investigation into their contributions to health and disease, as well as their therapeutic potential. Of these, mesenchymal stem cells (MSCs) are the most widely studied in human clinical trials, which have demonstrated a modulatory role in vascular physiology and disease. This review highlights the most recent knowledge surrounding the cell biology of MSCs, including their origin, identification markers and differentiation potential. The limitations concerning the implementation of MSC therapy are considered and novel solutions to overcome these are proposed.

Topics & Concepts

Mesenchymal stem cellStem cellDiseaseVascular wallMedicineEndothelial stem cellStem-cell therapyIdentification (biology)BiologyPathologyImmunologyCancer researchCell biologyIn vitroInternal medicineBotanyBiochemistryMesenchymal stem cell researchBiomarkers in Disease MechanismsMicroRNA in disease regulation
Mechanisms Underlying the Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis | Litcius